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Summary
Optimal two-treatment, p period crossover designs for binary responses are determined. The
optimal designs are obtained by minimizing the variance of the treatment contrast estimator over
all possible allocations of n subjects to 2p possible treatment sequences. An appropriate logistic
regression model is postulated and the within subject covariances are modeled through a working
correlation matrix. The marginal mean of the binary responses are fitted using generalized esti-
mating equations. The efficiencies of some crossover designs for p = 2, 3, 4 periods are calculated.
The effect of misspecified working correlation matrix on design efficiency is also studied.
Some key words: Binary response; Generalized estimating equations; Logistic regression; Efficiency.
1. Introduction
Crossover trials, wherein every experimental subject is exposed to a sequence of treatments over
different periods of time, have been applied in a variety of areas; see for example Jones & Kenward
(2014) and Senn (2003) for real life examples. The problem of determining optimal designs for
crossover trials has been studied quite extensively in recent years and we refer to Bose & Dey
(2009) for a review of results on optimal crossover designs. Most of the available results on optimal
1Corresponding author
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crossover designs relate to situations where the response variable is continuous. However, there
are situations in practice where the response in a crossover trial is binary in nature. For example,
consider a trial reported by Senn (2003, page 127) wherein it was desired to study the effect of
two drugs on 24 children aged 7 to 13 suffering from exercise-induced asthma. The two treatments
were, a single dose of 12µg formoterol solution aerosol, treatment A and a single dose of 200µg
of salbutamol solution aerosol, treatment B. Each child was given both the treatments either in
the order, AB or BA. The response variable was binary in nature taking value 1 if the drug was
effective and 0 otherwise. An equal number of children were allocated to each treatment sequence,
AB or BA. Is this the best design to be used in this situation?
In clinical or pharmaceutical research, the outcome of interest is often binary in nature. While
methods for analysing binary data arising from crossover trials are available in Jones & Kenward
(2014) and Senn (2003), the question of designing such studies in an optimal manner does not seem
to have been addressed. Waterhouse et al. (2006) considered crossover designs for binary response,
where the treatments were taken to be continuous in nature and no period effects were considered
in the model.
In this article, optimal crossover designs are studied when the response variable is binary. We
consider crossover trials with two treatments and p periods. The proposed designs minimize the
variance of the estimator of treatment contrast of direct effects over all possible allocation of the
n subjects to the treatment sequences. In the logistic regression model considered, both direct
effect as well as the carryover effect of each treatment are considered, wherein we assume that the
carryover effect of a treatment lasts only to the next succeeding period. While analysing data from
binary crossover trials, often it is assumed that all observations are mutually uncorrelated; however
this is not a very realistic assumption. We therefore assume that the p observations from each
subject are mutually correlated while the observations from different subjects are uncorrelated.
The correlation between observations within subjects are modeled using a “working correlation
structure”. Since the main interest is in estimating the treatment effects, we treat the subject
effects as a nuisance parameter and use the generalized estimating equations of Liang & Zeger
(1986) to estimate the marginal means. Though estimating equations were used earlier by Jones
& Kenward (2014) to analyse repeated measures data, their models did not include the carryover
effect.
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The variance of the treatment effect estimator depends on the model parameters. To address
the issue of parameter dependence, local optimal designs are found for given values of the model
parameters. For p = 2, 3, 4, we study the effect of two working correlation structures, equi-correlated
and autoregressive (AR) on the designs chosen. We also look at the effect of misspecification of the
covariance on the design efficiency.
In §2, we define the crossover logistic model for a binary response and discuss the estimation of
the crossover model using generalized estimating equations. In §3, results on optimal two-treatment
designs for 2, 3 and 4 periods are given.
2. The model and estimation
Consider a crossover trial involving t treatments, n subjects and p periods. Suppose the response
obtained from the jth subject is Yj = (Y1j , . . . , Ypj)
′, where a prime denotes transposition. Instead
of specifying a joint distribution of the repeated measurements we use a working generalized linear
model (GLM) to describe the marginal distribution of Yij as in Liang & Zeger (1986),
f(yij) = exp[{yijφij − b(φij) + c(yij)}ψ],
For a binary random variable Yij , φij = log
µij
1− µij
, b(φij) = log[1 + exp{φij}], c(yij) = 0, and the
scale parameter ψ is 1 (Robinson & Khuri, 2003). The mean of Yij is µij and variance µij(1−µij).
In a crossover setup, we model the marginal mean µij as
logit(µij) = ηij = µ+ βi + τd(i,j) + ρd(i−1,j); i = 1 . . . , p, j = 1, . . . , n, (1)
where µ is the overall mean, βi represents the effect of the ith period, τs is the direct effect due to
treatment s and ρs is the carryover effect due to treatment s, , s = 1, . . . , t. Throughout, 1u is a
u× 1 vector of all ones, Iu is the identity matrix of order u and 0ab is an a× b null matrix. Also,
we write β = (β1, . . . , βp)
′, τ = (τ1, . . . , τt)
′ and ρ = (ρ1, . . . , ρt)
′.
In matrix form the linear predictor corresponding to the jth subject, ηj = (η1j , . . . , ηpj)
′, can
be written as
ηj = Xjθ, (2)
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where θ = (µ, β, τ, ρ)′. The design matrix is Xj = [1p Pj Tj Fj ], where Pj = Ip; T = (T
′
1, . . . , T
′
n)
′,
where Tj is a p× t matrix with its (i, s)th entry equal to 1 if subject j receives the direct effect of
the treatment s in the ith period and zero otherwise; F = (F ′1, . . . , F
′
n)
′, where Fj is a p× t matrix
with its (i, s)th entry equal to 1 if subject j receives the carryover effect of the treatment s in the
ith period and zero otherwise.
The estimating equations of Liang and Zeger (1986) and Zeger et al. (1988) are used to estimate
the regression coefficients and to obtain their variances. It is assumed that measurements from
the same subject in the p periods are correlated while observations from different subjects are
uncorrelated.
The dependencies between repeated observations from a subject are modeled using a ”working
correlation” matrix R(α) where α is a vector of length s. If R(α) is the true correlation matrix of
Yj, then
Cov[Yj] = A
1/2
j R(α)A
1/2
j , (3)
where Aj = diag(µ1j(1− µ1j), . . . , µpj(1− µpj)). Let Vj = A
1/2
j R(α)A
1/2
j .
For a repeated-measures model, Zeger et al. (1988, equation (3.1)) define the generalized
estimating equations (GEE) to be
n∑
j=1
∂µ′j
∂θ
V −1j (Yj − µj) = 0,
where µj = (µ1j , . . . , µpj)
′. The asymptotic variance for the GEE estimator θˆ (see Zeger et al.
1988, equation (3.2)) is
V ar(θˆ) =

 n∑
j=1
∂µ′j
∂θ
V −1j
∂µj
∂θ


−1
, (4)
if Cov(Yj) = Vj. However, if the true correlation structure varies from the “working correlation”
structure, then V ar(θˆ) is given by the sandwich formula (Zeger et al. 1988, equation (3.2))
V ar(θˆ) =

 n∑
j=1
∂µ′j
∂θ
V −1j
∂µj
∂θ


−1 
 n∑
j=1
∂µ′j
∂θ
V −1j Cov(Yj)V
−1
j
∂µj
∂θ



 n∑
j=1
∂µ′j
∂θ
V −1j
∂µj
∂θ


−1
. (5)
For the crossover model (1), the ith element of
∂µj
∂θ is
∂µij
∂θ = x
′
ijµij(1 − µij), where x
′
ij is the
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ith row of Xj for i = 1, . . . , p.
For finding optimal crossover designs for the logistic model we use the approximate theory as
in Laska & Meisner (1985) and Kushner (1997, 1998). For a review of results on optimal crossover
designs using the approximate theory, we refer to Bose & Dey (2009, Chapter 4). Fixing the
number of subjects to n and periods to p, we determine the proportion of subjects assigned to a
particular treatment sequence. Each treatment sequence is of length p and a typical sequence can
be written as ω = (t1, . . . , tp)
′, ti ∈ {1, . . . , t}. Let Ω be the set of all such sequences. We denote
by nω the number of subjects assigned to sequence ω. Then, n =
∑
ω∈Ω nω, nω ≥ 0. A design ζ
in approximate theory is specified by the set {pω, ω ∈ Ω} where pω = nω/n, is the proportion of
subjects assigned to treatment sequence ω.
Note that the matrices Tj and Fj depend only on the treatement sequence ω to which the jth
subject is assigned, so Tj = Tω, Fj = Fω; see Lemma 4.2.1 in Bose & Dey (2009). This implies,
Xj = Xω. Since npω subjects are assigned to treatment ω, the variance of θˆ is
V arζ(θˆ) =
[∑
ω∈Ω
npω
∂µ′ω
∂θ
V −1ω
∂µω
∂θ
]−1 [∑
ω∈Ω
npω
∂µ′ω
∂θ
V −1ω Cov(Yω)V
−1
ω
∂µω
∂θ
][∑
ω∈Ω
npω
∂µ′ω
∂θ
V −1ω
∂µω
∂θ
]−1
.
(6)
As before, if the true correlation of Yj is equal to R(α) then
V arζ(θˆ) =
[∑
ω∈Ω
npω
∂µ′ω
∂θ
V −1ω
∂µω
∂θ
]−1
. (7)
In crossover trials the main interest usually lies in estimating the direct treatment effect con-
trasts. Thus, instead of working with the full variance-covariance matrix of θˆ we concentrate on
V ar(τˆ) where,
V arζ(τˆ ) = EV arζ(θˆ)E
′, (8)
where E is a t×m matrix given by [0t1, 0tp, It, 0tt] and m is the total number of parameters in θ.
An optimal design is one which minimizes the variance of τˆ over the set of all possible allocations
of the n subjects to the 2p treatment sequences.
3. Two treatment crossover trials: results and discussion
The optimality and efficiency of two-treatment crossover designs for continuous responses have
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been studied by various authors, including Kershner & Federer (1981), Laska & Meisner (1985),
Matthews (1987) and Carriere & Huang (2000). With two treatments of interest, the problem
simplifies to minimizing the variance of the treatment contrast τ1 − τ2 to obtain optimal crossover
designs. Reparametrizing model (1) as in Laska & Meisner (1985), using τ = (τ1 − τ2)/2 and
ρ = (ρ1 − ρ2)/2 we get
logit(µij) = µ+ βi + τΦd(i,j) + ρΦd(i−1),j), (9)
where ΦA = 1,ΦB = −1 and Φd(0,j) = 0.
For illustration we go back to the example in §1, where there are two treatments, A and B
applied in two periods to each child. The design used involved the treatment sequences AB and
BA, with equal allocation to each treatment sequence. Thus, the matrix Xω depends on the
treatment sequence ω ∈ Ω = {AB,BA}. If the treatment sequence, for example is ω = {AB}, then
Xω =

 1 1 0 1 0
1 0 1 −1 1


In the following, we look at the performance of the design, {AB,BA}. Senn (2003) fitted a logistic
model with no carryover effect to the data set and computed confidence intervals for the various
components of θ. Using these intervals we investigate if the above two-period design is the best
choice in the given situation. We also look at general situations for determining optimal designs
when p = 2, 3 or 4 for the two treatment case.
3.1 Designs compared. The designs that we consider are the same as those discussed by Laska &
Meisner (1985) and Carriere & Huang (2000) and are listed below for p = 2, 3 and 4:
(i) p = 2:
Design 1: AB and BA; Design 2: AB, AA, BA and BB, with equal number of subjects assigned
to each sequence.
(ii) p = 3:
d1: ABB and BAA, with optimal allocation to each treatment sequence;
d2: ABB and BAA;
d3: ABB, AAA, BAA and BBB;
d4: ABB, AAB, BAA and BBA;
6
d5: ABB, ABA, BAA and BAB;
d6: AAA and BBB.
In designs d2 − d6, each treatment sequence is allocated equally.
(iii) p = 4:
I: AABB, BBAA, ABBA, BAAB, with optimal allocation to each treatment sequence;
II: AABB, BBAA, ABBA and BAAB;
III: AABB, BBAA;
IV: ABBA, BAAB.
In designs II-IV, each treatment sequence is allocated equally.
For evaluating and comparing the above designs we define an efficiency measure as
Eff(ζ) =
(
V arζ∗(τˆ)
V arζ(τˆ)
)1/m
, (10)
where ζ∗ is the optimal crossover design obtained.
3.2. Working correlation structures. We consider the uncorrelated, compound symmetric or, equi-
correlated and the AR(1) structures for the correlation matrix R(α). Under the equi-correlated
covariance structure, Rj = (1− α)Ip + αJp.
Under the AR(1) assumption,
Rj = α
|i−i′|, i 6= i′
3.3 Results. We begin with the design for the trial reported in §1. A model without the carryover
effect is fitted to the binary data. The parameter estimates and confidence intervals for the pa-
rameters are: µ ∈ [1.1573, 5.0893]; τ ∈ [−5.1738,−1.4029]; β ∈ [−2.8390, 0.4932], as listed in Senn
(2003). A parameter space for θˆ is set up by taking Cartesian product of the confidence intervals.
Under uncorrelated error structure, the efficiency of both designs 1 and 2 are the same. For the
equi-correlated error structure, we take α = 0.2, 0.4 for finding the best design. The performance of
the design {AB,BA} is studied through the distribution of the efficiency values in the parameter
space and compared with the design {AB,BA,AA,BB}. During comparisons 10, 000 values are
randomly selected from the parameter space and the efficiencies computed. It is found that design
1 is substantially superior to design 2 in terms of median and minimum efficiencies. Furthermore,
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the efficiency of design 1 is less affected by an increase in the value of α.
We next determine optimal crossover designs for p = 2, 3, 4 under the correlation structures
stated earlier. For logistic models, the variance of τˆ depends on the parameter values. To address
the issue of parameter dependence we use various parameter spaces, B1 − B6. For an explanation
of the different parameter spaces considered, see Table 1. For instance, suppose p = 2 and the
parameter space is B1. Then, µ ∈ [−0.5, 0.5], β1 ∈ [−1, 1], β2 ∈ [−1, 1], τ ∈ [−1.5, 1.5], ρ ∈ [−1, 1]
and α = 0.2. For each value of p, the designs listed in subsection 3.1 are compared by choosing
10, 000 values from each of the six parameter spaces B1−B6. The performance of these designs are
examined by noting their minimum and median efficiencies. The length of the parameter intervals
considered in B1 − B3 are more when compared to those from B4 − B6. This enables us to study
the effect of increasing parameter uncertainty on the chosen designs.
3.3.1. Estimation of direct treatment effects in the presence of carryover effects. When the carryover
effect is included in the model and p = 2, we only consider design 2 for estimation of direct treatment
effects, because, as noted by Bose & Dey (2015), design 1 does not permit the estimation of contrasts
among direct effects. First, let us consider the uncorrelated error structure. All designs for p = 2, 3
and 4 are compared over parameter spaces B1 and B4. It is seen that design 2 has high median
efficiency (99%) for p = 2 (see Table 2).
For p = 3 the distribution of efficiencies of the designs are presented in Table 3. From this
table we note that design d4 performs the best followed closely by designs d1 and d2. Design d6 is
the worst. The performance of design d4 is not much affected by increasing lengths of parameter
intervals. Under uncorrelated errors for p = 4, design I performs the best in terms of median and
minimum efficiencies (see Table 4). On the average design I allocates equal proportion of subjects
to each treatment sequence.
We next consider a compound symmetric correlation structure for the errors. All designs were
compared over six parameter spaces, B1 − B6. For a model including carryover effects and p = 2,
design 2 has 99% median efficiency (see Table 2). Thus, as in the case of continuous responses
(Laska & Meisner, 1985), design 2 performs well even under a logistic model. Design 2 is also not
much affected by changes in the correlation parameter and in the lengths of the parameter intervals.
The distribution of efficiencies of the designs for p = 3 are presented in Table 3. From the table
we see that with respect to median efficiency, the design d1 with optimal allocation of subjects to
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each sequence is the best, very closely followed by designs d2 and d4. The median efficiencies of
these three designs are also not affected by increasing α. The minimum efficiency values of design
d4 are the highest. The effect of increasing α is more on the minimum efficiencies values of designs
d1 and d2 as compared to d4. Thus, on the basis of both median and minimum efficiencies, the
performance of design d4 is the best among the six designs compared. Design d6 has the worst
efficiency values and its performance is affected by increasing values of α. Note that under the
continuous response case, d2 with equal allocation to sequences ABB and BAA is known to be the
universally optimal design within the class of three-period designs for equi-correlation (Laska &
Meisner, 1985).
For p = 4, median efficiencies of all designs I-IV are at least 98%, and do not change with
increasing α (see Table 4). However, when designs are compared with respect to minimum efficien-
cies, design I is the best closely followed by design II, unchanged with changes in the correlation.
Both designs III and IV record lower minimum efficiency values, which decrease with increasing α.
On the average design I allocates n/4 subjects to each sequence. For the normal linear model case,
Laska & Meisner (1985) showed that design II is optimal.
Finally we consider the AR(1) correlation structure. For p = 3, designs d1, d2 and d4 record at
least 99% median efficiency values (see Table 3). However, the minimum efficiencies of designs d1
and d2 are lower than those of design d4 and are also affected by increasing correlation. Even for
the AR(1) structure, we see that the best design is d4 on the basis of both minimum and median
efficiencies and it is also least affected by increasing α. Design d6, with equal allocation to sequences
AAA and BBB is the worst among the designs compared. Laska & Meisner (1985) showed that
for p = 3 in the continuous response case, design d4 is optimal. However for all α more individuals
were allocated to sequence AAB and its dual.
Under the AR(1) structure, for p = 4, design I is the best design with highest median and
minimum efficiencies. Designs III and IV do not perform well, their minimum efficiencies are lower
and decrease with increasing α (see Table 4).The average allocations of design I is studied, the
results show that for low values of α, the sequence ABBA and its dual each gets 35% allocation
while, sequence AABB and its dual get 15% allocation. As α increases to 0.4, 85% individuals
are allocated to ABBA and its dual, while for α = 0.6, it is 92%. Thus, as α increases almost no
subjects are allocated to sequence AABB and its dual. Our result matches with those of Laska &
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Meisner (1985) and Matthews (1987) when the response is continuous.
3.3.2. Estimation of carryover effects. Although direct treatment effects are generally of primary
interest in crossover trials, we present some results on optimal designs for estimating carryover
effects as well for the uncorrelated, equicorrelated and AR(1) structures. For p = 3, 4, the parameter
spaces considered are B1 − B3.
In the uncorrelated error case for p = 3, we note that d4 performs the best with 99.51% median
and 96.23% minimum efficiencies. The median efficiencies of d1 and d2 are also at least 99%;
however their minimum efficiencies (90%) are much lower than those under d4 (96%).
For the equicorrelated and AR(1) covariance structures, d1 and d2 have 99% median efficiencies
and at least 90% minimum efficiency values. Also the performance of designs d1 and d2 do not
change with increasing correlation. However, unlike in the estimation of direct treatment effect the
performance of d4 is not good and is affected by changes in α. Median efficiency of d4 dcreases
to 94% and minimum efficiency to 90% as α increases to 0.6. Design d6 is the worst among the
designs compared as before. On the average d1 allocates equal (n/2) subjects to sequence ABB
and its dual. For the normal case under AR(1) covariance structure, Matthews (1987) showed that
d2 has 100% efficiency for α = 0.2, 0.4, 0.6.
When p = 4, under all three covariance structures, design I performs the best with respect to
minimum and median efficiencies. Under uncorrelated and compound symmetric covariances, the
average allocation of design I is n/4 to each sequence. However, under AR(1), as α increases more
subjects get allocated to sequence AABB and its dual than sequence ABBA and its dual. In the
normal response case under AR(1) covariance structure, Matthews (1987) showed that design with
sequences AABB, ABBA and their duals has at least 85% efficiency for positive α.
3.4. Effect of covariance misspecification
So far we have assumed that the true correlation structure of the responses is equal to the
working correlation structure. However, this may not be true in most cases. To see the effect
of varying structures on the efficiency of the designs, we carry out a simple study We set p = 3
and use parameter spaces B5 and B6. The working correlation structure is taken to be compound
symmetric and the true correlation AR(1). The designs studied are d1, d2 and d4. The distribution
of efficiencies of the three designs when working and true structures are assumed to be equal are
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already given in Table 3.
For finding the efficiency of the designs when there is misspecification we use (6) in the variance
formula and report the results in Table 5. We see that the performance of all designs are affected;
however designs d1 and d2 suffer much more than d4. In case of α = 0.4, the median efficiencies
of designs d1 and d2 reduce to 97%, and to 94% when α is 0.6. The efficiency of design d4 is at
least 97% for α = 0.4, 0.6. The minimum efficiencies of designs d1 and d2 are affected much more
than design d4 and also more when we consider a higher value of α. Thus, design d4 appears to
be the best design to use when we have carryover effects in the model as it also guards against
misspecification in covariance.
3.5. Concluding Remarks. Crossover designs for binary responses are compared for p = 2, 3, 4.
Since these designs depend on the parameter values, intervals of the parameters are considered and
local optimal designs are found in each case. The main results on the estimation of direct effects
are summarized below.
For p = 3 design d4 is seen to be the best design for uncorrelated, equicorrelated and AR(1)
covariance structures. For p = 4 design I is seen to be the most efficient design for uncorrelated,
equicorrelated and AR(1) covariance structures. In the equicorrelated case, on average design I
allocates equal number of subjects to the treatment sequences. However, in the AR(1) case, the
average optimal allocation depends on the correlation parameter α. The results found in the logistic
regression case for p = 2, 3, 4 are very similar to available results in the continuous case.
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Table 1: Parameter spaces
Parameters µ βi (for each i = 1, 2, 3, 4) τ ρ α
Range
B1 [-0.5, 0.5] [-1.0, 1.0] [-1.5, 1.5] [-1.0, 1.0] 0.2
B2 [-0.5, 0.5] [-1.0, 1.0] [-1.5, 1.5] [-1.0, 1.0] 0.4
B3 [-0.5, 0.5] [-1.0, 1.0] [-1.5, 1.5] [-1.0, 1.0] 0.6
B4 [-0.5, 0.5] [-1.0, 1.0] [-0.2, 1.5] [-0.2, 1.0] 0.2
B5 [-0.5, 0.5] [-1.0, 1.0] [-0.2, 1.5] [-0.2, 1.0] 0.4
B6 [-0.5, 0.5] [-1.0, 1.0] [-0.2, 1.5] [-0.2, 1.0] 0.6
Table 2: Efficiencies (minimum, median) of design (D2) compared to the optimal design D
∗ for 2-
periods 2-treatments with carry-over effect model. Correlation Structures (Corr. st.) are compound
symmetric (CS) and uncorrelated (Ind.).
Par. Space Corr. St. D2
B1
CS (0.9639, 0.9977)
Ind. (0.9599, 0.9974)
B2 CS (0.9539, 0.9975)
B3 CS (0.9595, 0.9972)
B4
CS (0.9738, 0.9983)
Ind. (0.9664, 0.9977)
B5 CS (0.9749, 0.9981)
B6 CS (0.9734, 0.9980)
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Table 3: Estimation of direct treatment effect. Efficiencies (minimum, median) of designs d1 − d6 as compared to the optimal design D
∗
for 3-periods 2-treatments model. Correlation Structures (Corr. st.) are compound symmetric (CS), AR(1) and uncorrelated (Ind.).
Par. Space Corr. St. d1 d2 d3 d4 d5 d6
B1
CS (0.9364, 0.9972) (0.9355, 0.9964) (0.9135, 0.9487) (0.9744, 0.9972) (0.9382, 0.9668) (0.7514, 0.8139)
AR(1) (0.9381, 0.9945) (0.9374, 0.9938) (0.9244, 0.9636) (0.9704, 0.9960) (0.9409, 0.9714) (0.7629, 0.8318)
Ind. (0.9434, 0.9960) (0.9423, 0.9952) (0.9304, 0.9686) (0.9742, 0.9979) (0.9390, 0.9682) (0.7720, 0.8378)
B2
CS (0.9293, 0.9974) (0.9291, 0.9966) (0.8964, 0.9308) (0.9707, 0.9959) (0.9337, 0.9658) (0.7255, 0.7796)
AR(1) (0.9309, 0.9917) (0.9309, 0.9910) (0.9054, 0.9503) (0.9657, 0.9939) (0.9350, 0.9708) (0.7438, 0.8141)
B3
CS (0.8955, 0.9971) (0.8955, 0.9963) (0.8830, 0.9156) (0.9659, 0.9943) (0.9247, 0.9650) (0.6803, 0.7315)
AR(1) (0.9027, 0.9860) (0.9027, 0.9853) (0.8813, 0.9290) (0.9579, 0.9912) (0.9195, 0.9662) (0.6978, 0.7749)
B4
CS (0.9501, 0.9982) (0.9497, 0.9976) (0.9294, 0.9511) (0.9813, 0.9975) (0.9396, 0.9645) (0.7565, 0.8138)
AR(1) (0.9467, 0.9961) (0.9461, 0.9954) (0.9417, 0.9666) (0.9821, 0.9970) (0.9415, 0.9690) (0.7680, 0.8328)
Ind. (0.9501, 0.9973) (0.9489, 0.9966) (0.9446, 0.9725) (0.9853, 0.9986) (0.9403, 0.9651) (0.7699, 0.8375)
B5
CS (0.9408, 0.9984) (0.9407, 0.9977) (0.9132, 0.9326) (0.9776, 0.9958) (0.9392, 0.9636) (0.7271, 0.7795)
AR(1) (0.9310, 0.9937) (0.9308, 0.9931) (0.9233, 0.9533) (0.9773, 0.9953) (0.9369, 0.9689) (0.7478, 0.8160)
B6
CS (0.9201, 0.9983) (0.9200, 0.9975) (0.8910, 0.9166) (0.9735, 0.9941) (0.9290, 0.9631) (0.6838, 0.7314)
AR(1) (0.9036, 0.9881) (0.9034, 0.9875) (0.8894, 0.9317) (0.9672, 0.9929) (0.9158, 0.9647) (0.7016, 0.7777)
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Table 4: Estimation of direct treatment effect. Efficiencies (minimum, median) of designs I − IV
compared to the optimal design D∗ for 4-periods 2-treatments model. Correlation Structures (Corr.
st.) are compound symmetric (CS), AR(1) and uncorrelated (Ind.).
Par. Space Corr. St. DI DII DIII DIV
B1
CS (0.9803, 0.9996) (0.9787, 0.9982) (0.9151, 0.9848) (0.9228, 0.9845)
AR(1) (0.9772, 0.9994) (0.9746, 0.9962) (0.9046, 0.9728) (0.9315, 0.9927)
Ind. (0.9767, 0.9985) (0.9759, 0.9970) (0.9180, 0.9840) (0.9245, 0.9838)
B2
CS (0.9805, 0.9996) (0.9792, 0.9983) (0.9000, 0.9845) (0.9164, 0.9842)
AR(1) (0.9754, 0.9999) (0.9678, 0.9906) (0.8816, 0.9571) (0.9204, 0.9972)
B3
CS (0.9733, 0.9996) (0.9707, 0.9982) (0.8894, 0.9837) (0.8860, 0.9837)
AR(1) (0.9720, 1.0000) (0.9592, 0.9829) (0.8591, 0.9404) (0.8975, 0.9986)
B4
CS (0.9878, 0.9997) (0.9847, 0.9986) (0.9504, 0.9876) (0.9186, 0.9811)
AR(1) (0.9870, 0.9996) (0.9837, 0.9973) (0.9369, 0.9761) (0.9275, 0.9911)
Ind. (0.9875, 0.9989) (0.9855, 0.9977) (0.9520, 0.9872) (0.9228, 0.9812)
B5
CS (0.9917, 0.9997) (0.9840, 0.9987) (0.9368, 0.9872) (0.8999, 0.9810)
AR(1) (0.9807, 1.0000) (0.9770, 0.9926) (0.9163, 0.9607) (0.9151, 0.9969)
B6
CS (0.9899, 0.9997) (0.9834, 0.9988) (0.9306, 0.9868) (0.8859, 0.9809)
AR(1) (0.9720, 1.0000) (0.9644, 0.9852) (0.8835, 0.9448) (0.9030, 0.9988)
Table 5: Efficiencies (minimum, median) of designs d1, d2 and d4 under misspecification of correla-
tion structure.
Par. Space d1 d2 d4
B5 (0.9124, 0.9716) (0.9120, 0.9710) (0.9651, 0.9821)
B6 (0.8713, 0.9456) (0.8709, 0.9448) (0.9456, 0.9670)
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